SCHEMBL4353549

SCHEMBL4353549

COc1ccc(Oc2cccc(CNc3cccc(F)c3O)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 3/20 0.54
HTT P42858 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
ABCB1 P08183 3/20 0.49
ABCG2 Q9UNQ0 2/20 0.49
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48
HDAC8 Q9BY41 2/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 2/20 0.47
MMP13 P45452 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ACP1 P24666 1/20 0.44
FFAR1 O14842 2/20 0.44
GRM2 Q14416 1/20 0.42
POLB P06746 1/20 0.41
CRHBP P24387 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351109 0.90 FFAR1 (0.51) ALDH1A1KDM4EHTTSMN1; SMN2GAA
SCHEMBL4356057 0.88 ALDH1A1 (0.52) ALDH1A1KDM4EHTTSMN1; SMN2ABCB1
SCHEMBL4345590 0.88 MEN1 (0.44) ALDH1A1KDM4EHTTSMN1; SMN2LMNA
SCHEMBL4351710 0.87 FAAH (0.42) ALDH1A1KDM4EHTTSMN1; SMN2ABCB1
SCHEMBL4354025 0.85 KDM4E (0.54) ALDH1A1KDM4EHTTSMN1; SMN2ABCB1
SCHEMBL4356184 0.84 KDM4E (0.55) ALDH1A1KDM4EHTTSMN1; SMN2GAA
SCHEMBL4346815 0.80 MAPT (0.58) ALDH1A1KDM4EHTTSMN1; SMN2GAA
SCHEMBL4346864 0.79 ALDH1A1 (0.55) ALDH1A1KDM4EHTTSMN1; SMN2ABCB1
SCHEMBL4350844 0.79 HTT (0.55) ALDH1A1KDM4EHTTSMN1; SMN2ABCB1
SCHEMBL4345422 0.78 FFAR1 (0.49) ALDH1A1KDM4EHTTSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-1539683-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS Jerini AG (DE) 2005-06-15 EP claimed
WO-2004030664-A2 NEW COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF JERINI AG (DE) 2004-04-15 WO claimed
WO-2004026815-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS JERINI AG (DE) 2004-04-01 WO claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 ALDH1A1 2565/4885KDM4E 2662/4885HTT 3824/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 ALDH1A1 2767/4885KDM4E 1689/4885HTT 3995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.